PAR 0.00% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice - Rennie, page-34

  1. 4,137 Posts.
    lightbulb Created with Sketch. 6621
    If I can cut in, I think FriendsandCo was eluding to the fact that whoever we partner up in the MPS and Lysosomal space will then start to create a monopoly. There are a number of providers (around 15 or so)...BUT NONE of them offer pain relief. iPPS offers this as well as function improvement, increase in ROM as well as decreased Urinary Gags. This is not as evident in ERT and other solutions.

    Whoever partners here with us will have these features and benefits OVER AND BEYOND the current competition. That will be worth something.

    Lucrative.

    This may only be months away? (my spec views, could be longer?)

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.000(0.00%)
Mkt cap ! $87.44M
Open High Low Value Volume
26.0¢ 26.0¢ 25.0¢ $70.91K 279.9K

Buyers (Bids)

No. Vol. Price($)
3 75357 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 116338 2
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
25.0¢
  Change
0.000 ( 0.16 %)
Open High Low Volume
25.5¢ 26.0¢ 25.0¢ 98848
Last updated 15.58pm 04/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.